Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.
Dreyer L, Magyari M, Laursen B, Cordtz R, Sellebjerg F, Locht H
Ann Rheum Dis. 2015 Dec 23. PMID: 26698850.Abstract